Wound Care Markets (Skin Ulcer Treatment, Burn Treatment, Hydrocolloids, Adhesives, Pressure Relief, Silver, Regenerative Products, Trauma Care, NPWT, Dressings, Tapes, Debridement, Collagen, Staples, Sutures, and Other Devices)
Advanced Wound Care: A Global Market of Over 20 Billion Dollars
The worldwide wound care market reached revenues of $20,980.7 million in 2016 based on sales at the manufacturers’ level. The market is varied in terms of both offerings of medical devices used for wound care and product maturity. Several of the medical devices within the worldwide wound care market are mature such as anti-infectives and pressure relief devices, while others such as biological dressings and negative pressure wound therapy are in the growth stages of development. Thus, some products within the market are slowing in growth rates while others are driving growth.
Kalorama Information's Wound Care Markets provides useful information to business planners in the healthcare industry including market size estimates for various wound care market segments, forecasts, trend analysis, competitive analysis, corporate profiles, market share and other information. The worldwide wound care market is a technologically enriched environment dedicated to advancing wound care therapies. Overall, the industry is showing renewed signs of growth as the demand for products remains strong. Wound care is a balancing act due to the aging population and co-morbidity of diseases such as diabetes, cardiovascular disease, obesity and other diseases that present an ever-present challenge to wound care practitioners and manufacturers alike.
Skin Ulcers Wound Treatment
Skin ulcer wound treatment is a complex, intricate series of events influenced byinternal and external conditions. Factors that influence the events of the wound-healingcascade are determined by deficiencies and comorbidities of the patient in addition tothe environment of the wound. Treatments for skin ulcer wounds vary according to thetype of wound and the individual needs of the wound but include the following categories:
- Skin Ulcer Wound Management
- Moist Dressings
- Negative Pressure Wound Therapy
- Biological Dressings
- Pressure Relief Devices
- Miscellaneous Skin Ulcer Treatments
Burn wound care and treatment consists of measures to limit bacterial infection in thewound and on adjacent tissue. The burn has left the body susceptible to seriousinfection. The first line of defense, the skin, has been destroyed by the burn injury. Atfirst, burn wounds are sterile because of the heat that caused the burn, but bacterial florasoon re-establishes colonies on the burned skin or Escher. The medium is favorable forpathogenic growth because of the necrotic tissue and warm environment that existwithin the burn wound dressing. Benign microorganisms normally found on the skin, inthe gastrointestinal tract, and in the pulmonary system become lethal as they colonizethe burn wound and invasive sepsis occurs. Burn recovery is long and with complications the rule rather than theexception.
- Burn Anti-infectives
- Burn Injury Management
- Burn Moist Dressings
- Burn Biological Dressings
- Burn Pressure Relief Devices
- Miscellaneous Burn Treatments
Surgical Trauma & Wound Treatment
- Wound closure
- Wound management
- Moist dressings
- Biological dressings
- Miscellaneous treatments
Wound Care Companies:
- 3M Health Care
- ABL Medical, LLC
- Acelity L.P. Inc.
- Acell, Inc
- Alliqua Biomedical, Inc.
- Amniox Medical
- Angelini Pharma, Inc
- Argentum Medical, LLC
- Arobella Medical, LLC
- Baxter Bioscience
- B. Braun/Aesculap, Inc.
- BSN Medical, Inc.
- Cardinal Health, Inc
- Coloplast A/S
- ConvaTec, Inc.
- Crawford Healthcare Ltd.
- Cyrolife, Inc.
- Curaline, Inc.
- Derma Sciences
- DeRoyal Industries
- EHOB, Inc
- Ethicon, Inc.
- GlaxoSmithKline, Plc.
- Hartmann USA, Inc
- Hill-Rom Company, Inc.
- Hollister Wound Care, LLC
- Integra Life Sciences
- Johnson & Johnson
- Lifebond Ltd.
- Lohmann and Rauscher GmbH & Co. KG
- Marine Polymer Technologies, Inc.
- Medline Industries, Inc
- Medtronic Plc
- MiMedx Group, Inc
- MoInlycke Healthcare, LLC
- MPM Medical, Inc.
- Oculus Innovative Sciences, Inc
- Organogenesis, Inc.
- Osiris Therapeutics, Inc.
- Pfizer, Inc.
- Smith & Nephew, Plc
- Soluble Systems, LLC
- Southwest Technologies
- SteadMed Medical
- Stryker Corp
Medical Devices in The Wound Care Market
There have been many research advancements in the last decade. However, recently these advancements are taking place on a daily basis with the most significant changes in the past 30 years. New developments are providing the health care arena of today with some truly sophisticated, highly effective wound care treatments. With respect to wound dressings, the focus has been more on their categories rather than on their functions. Recent discussions have surfaced in literature that take note of this situation. There is a decided move for a paradigm shift in decision making about dressings. The shift is described as the interactive and active use of dressing materials in the same way as drugs, with specific actions, interactions, contraindications, indications, and side effects.
The emerging generation of wound care medical devices and technologies are well positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.
The worldwide wound care market is based on total manufacturers’ revenues. The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 100 face-to-face, telephone and email interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
All market data pertains to the global market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2016. Historical data are provided for each of the years 2014 through 2016, and forecast data are provided for each of the years 2016 through 2021. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2016 base year.
Q&A With Advanced Wound Care Market Analyst:
Q: What are some of the challenges facing the market?
A: There is significant market potential for advanced wound care products if barriers such as cost and ‘old school’ attitudes can be overcome. Many physicians are reluctant to deviate away from the tried and true traditional wound care products. Education and familiarity with these new products coupled with demonstrated cost savings will propel the market forward
Q: What is driving wound care sales?
A: You reap what you sow in this business Growth will be driven by technologically advanced products and therapies that are more cost effective and clinically efficient. On-going research and development of products is essential for future development of the industry. The goal is still to provide products that improve efficacy and control costs.
Other than that there are traditional factors. Aging of the population will have several varied effects on the healthcare industry as a whole, with specific implications for wound care. First, aging of the population will bring increased prevalence of chronic diseases—such as asthma, chronic obstructive pulmonary disorder (COPD), congestive heart failure (CHF), coronary heart disease (CHD), diabetes and osteoarthritis—which are more prevalent among the elderly. This will increase the need for wound care among the elderly population.
In addition, the elderly population itself is changing.
The global population above age 65 is expected to grow by 279% between 2000 and 2050. This growth is showing the fastest increase from 2040 through 2050 showing a progressive rise in the aging population.
In comparison, the total global population is expected to increase by 54% between 2000 and 2050 (6.1 billion to 9.4 billion).
Q: What trends uncovered in the research?
A: Pressure relief is an area of great demand but great challenge. Presure injuries are common in the old population. CMS is making a decision on pressure injuries in heatlhcare setting that they will not reimburse secondary visits for relief treatments. . The Healthcare Cost and Utilization Project released information involving the treatment of pressure injuries in 2006. In 2006, there were 503,300 hospital stays during which pressure injuries were noted- a 78.9% increase from 1993 when there were about 281,300 hospital stays related to pressure injuries. During the same period, however, the total number of hospitalizations increased by only 15%.
Apps are another interesting. There are apps available everywhere for most everything and wound care is no exception. MoInlycke Healthcare launched an iPhone application for its Avance Negative Pressure Wound Therapy System. The app includes dressing application guides for the Avance system, access to customer services and details for ordering. The app can be downloaded on an iPhone, iPad or iPod Touch currently and the company is working on adding formats for other smartphones. Other companies are introducing their versions of apps for products in their line. It is expected that this application of technology will continue to grow in the future and become more common place in the industry.
Some examples of apps include the MOWA- Mobile Wound Analyzer - which is an application for advanced management of pressure injuries, diabetes and vascular disease. It is sophisticated and practical software for analyze images of ulcers and may also be useful as a reference manual and guide for post -visual evaluation. It is target to health professionals who heal wounds or want to learn how to heal wounds.
We are likely to see more apps in the future that are more intuitive and incorporate more assessment information.
Q: How is the Regulatory environment for wound care?
A: Changes are abundant. Over the past few years, there have been many regulatory changes and issues involving wound care. Some of the more notable changes that have directly impacted the market include:
- Sunshine Physician Payment which requires medical manufacturers to report payments or other transfers of value to covered recipients i.e. physicians, hospitals etc. Start date for the tracking was August 1, 2013 and it was to be reported to CMS by March 31, 2014.
- Medical Device Tax is a tax on the sale of certain medical devices by the manufacturer or importer of the device. The tax applies to sales after December 2012 and is 2.3 percent of the sale price of the taxable items. This encompasses most of the products in the wound care arena. In January 2016, there was a moratorium on the medical device tax until 2017. With a new administration in office, it remains to be seen if the medical device tax will be repealed or reinstated in 2017
- Unique Device Identifier (UDI) which is a unique numeric or alphanumeric code that includes a device identifier, batch number, serial number and expiration date.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.